Developer of an ultrasound image analysis platform intended to offer early disease detection and diagnosis. The company's platform uses artificial intelligence and machine learning to provide a decision support system that is trained on hundreds of thousands of images combined with data from pathology results, enabling healthcare institutions to detect and diagnose cancer with better accuracy along with improving clinical decision-making and overall quality of care.
Developler of non-invasive and radiation-free imaging modality technology designed to screen children at risk for kidney reflux to help in early detection. The company's technology is used for kidney reflux, removing the need for complicated procedures and hospital visits, enabling physicians to screen and monitor kidney reflux, and enhancing the patient experience and clinical outcomes.
Developer of a medical platform designed for imaging analysis. The company's platform uses artificial intelligence to identify abnormalities such as pleural effusion, and pneumonia with precision and integrates with existing ultrasound equipment, enabling healthcare providers to enhance patient outcomes and streamline workflows.
Developer of diagnostic tests intended for clinical trials. disease diagnosis, and monitoring. The company's platform leverages sensitive and portable technology to detect and quantify biomarkers at extremely low concentrations, enabling healthcare professionals to make accurate and timely decisions.